Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05744960

Impact of Financial Incentives

Conditions: Human Papilloma Virus

Sex: All
Ages: 9 Years – 12 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 34
Sponsor: UNC Lineberger Comprehensive Cancer Center

Location: University of North Carolina at Chapel Hill Chapel Hill North Carolina

Summary

This trial will look at the impact of clinic-level financial incentives to improve provider communication and increase HPV vaccine uptake. Some clinics will receive communication training. Other clinics will receive the same training and a clinic-level financial incentive program with a monthly data feedback report to increase HPV vaccine uptake.

Eligibility Criteria

This trial will enroll clinics and intervene with clinical staff. We will use vaccination data from children to evaluate intervention effectiveness. We will not enroll children or interact with them directly. Inclusion Criteria: Clinics are eligible if they are a pediatric or family medicine clinic in North Carolina that in the past year had: * less than 72% HPV vaccine initiation rate, * greater than or equal to 50 patients ages 9-12 * greater than or equal to 2 HPV vaccine providers * no clinic or provider-level financial incentive programs to increase system, clinic, or provider HPV vaccination rates among patients aged 9-12 in the past two years, and * no HPV vaccine provider communication trainings in the past six months. Children's medical records will be eligible to be included in the dataset if children: * are between the ages of 9-12 years at baseline and * are attributed to a participating clinic at 12- or 24-month follow-up. Exclusion Criteria: Clinics are excluded if they: * do not provide HPV vaccine to children ages 9-12 * have a specialty other than pediatrics or family medicine * had an HPV vaccine-specific financial incentive program in the past two years * had a formal HPV vaccine communication training in the past 6 months * had an HPV initiation rate greater than 72$ * had fewer than 49 patients aged 9-12 * had 1 or fewer HPV vaccine providers Children's medical records will not be eligible to be included in the dataset if children: * are not between the ages of 9-12 years at baseline * are not attributed to a participating clinic at 12- or 24-month follow-up

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05744960). StuddyBuddy aggregates publicly available trial information.